Argentina Pharmacovigilance and Drug Safety Software Market Size & Outlook, 2025-2033
Argentina Pharmacovigilance and Drug Safety Software Market Insights
- According to Reed Intelligence analysis, the Argentina Pharmacovigilance and Drug Safety Software Market size was USD 1.74 Million in 2024 and is projected to reach USD 3.12 Million by 2033.
- The Argentina market is projected to grow at a CAGR of 6.68% between 2026 and 2033.
- By segment, Case data collection and management emerged as the largest By Functionality in terms of market size in 2024.
- Adverse event reporting and analysis is anticipated to remain the most attractive By Functionality segment, recording the fastest growth during the forecast period.
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- Argentina contributed 0.85% to the global Pharmacovigilance and Drug Safety Software Market size in 2024.
- By 2033, United States is forecasted to remain the largest global market for Pharmacovigilance and Drug Safety Software Market.
- In LATAM, Brazil is projected to capture the leading share of market size by 2033.
- Among LATAM markets, Chile is expected to post the fastest growth, reaching USD 1.51 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 1.74 Million |
| Market Size In 2033 | USD 3.12 Million |
| Largest segment | Case data collection and management |
| Units | Revenue in USD Million |
| CAGR | 6.68% (2025-2033) |
| Segmnetation Covered | |
| By Functionality |
|
| By Delivery Mode |
|
| By End Use |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Argentina Pharmacovigilance and Drug Safety Software Market By Functionality 2025-2033 (USD Million)
| By Functionality | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Case data collection and management | XX.x | XX.x | XX.x | 0.81 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Adverse event reporting and analysis | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Signal detection and other safety risk assessment | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Argentina Pharmacovigilance and Drug Safety Software Market By Delivery Mode 2025-2033 (USD Million)
| By Delivery Mode | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| On Premise | XX.x | XX.x | XX.x | 0.96 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| On Demand | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Argentina Pharmacovigilance and Drug Safety Software Market By End Use 2025-2033 (USD Million)
| By End Use | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Healthcare Companies | XX.x | XX.x | XX.x | 0.86 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| CROs/BPOs/PV service providers | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Others | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
